MRI findings of rapidly progressive hepatocellular carcinoma

Magnetic Resonance Imaging

Volumn 28, Issue 6, 2010, Pages 790-796

  Kierans, Andrea S ^a   Leonardou, Polytimi ^a   Hayashi, Paul ^a   Brubaker, Lauren M ^a   Elazzazi, Mohamed ^a   Shaikh, Faiq ^a   Semelka, Richard C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Focal liver lesions; Hepatocelluar Carcinoma; Liver; MRI; Rapidly progressive

Indexed keywords

GADOBENATE DIMEGLUMINE; GADODIAMIDE; GADOLINIUM PENTETATE; CONTRAST MEDIUM; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CANCER GROWTH; CANCER SIZE; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HUMAN; IMAGE ANALYSIS; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER NODULE; LIVER TRANSPLANTATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; DIAGNOSTIC USE; DISEASE COURSE; FOLLOW UP; IMAGE ENHANCEMENT; IMAGE PROCESSING; LIVER; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

HEPATITIS C VIRUS;

ADULT; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 77953801657     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2010.03.005     Document Type: Article

References (27)

1. Takayama T., Makuuchi M., Kojiro M., Lauwers G.Y., Adams R.B., Wilson S.R., et al. Early hepatocellular carcinoma: pathology, imaging and therapy. Ann Surg Oncol 2008, 15:972-978.
2. Crocetti L., Lencioni R. Thermal ablation of hepatocellular carcinoma. Cancer Imaging 2008, 27:819-826.
3. Digumarthy S.R., Sahani D.V., Saini S. MRI in detection of hepatocellular carcinoma (HCC). Cancer Imaging 2005, 5:20-24.
4. Schimizu H., Katano Y., Nagano K., Yokozaki S., Shimizu F., Naito T., et al. Recurrent hepatocellular carcinoma with rapid growth after cardiac surgery. Hepatogastroenterology 2005, 52:1863-1866.
5. Wy A., Ak L., Liang R., Liu C.L., Shek T.W., Lau G.K. Aggressive hepatocellular carcinoma complicating pregnancy after autologus bone marrow transplantation for non-Hodgkin's lymphoma. Bone Marrow Transplant 2002, 29:177-179.
6. Hussain S.M., Semelka R.C., Mitchell D.G. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am 2002, 10:31-52.
7. Bialecki E.S., Di Bisceglie A.M. Diagnosis of hepatocellular carcinoma. HPB 2005, 7:26-34.
8. Willatt J.M., Hussain H.K., Adusumilli S., Marrero J.A. MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008, 247:311-330.
9. Seeff L.B. Natural history of hepatitis C. Hepatology 1997, 6(Suppl 1):21-28.
10. Hwang S.J., Lee S.D., Lu R.H., Chu C.W., Wu J.C., Lai S.T., et al. Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C. J Med Virol 2001, 36:392-398.
11. Cox A.L., Mosbruger T., Mao Q., Liu Z., Wang X.H., Yang H.C., et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 2005, 201:1741-1752.
12. Mastropasqua M., Braga L., Kanematsu M., Vaidean G., Shrestha R., Leonardou P., et al. Hepatic nodules in liver transplantation candidates: MR imaging and underlying hepatic disease. Magn Reson Imaging 2005, 23:557-562.
13. Taouli B., Goh J.S., Lu Y., Qayyum A., Yeh B.M., Merriman R.B., et al. Growth rate of hepatocellular carcinoma: evaluation with serial computed tomography or magnetic resonance imaging. J Comput Assist Tomogr 2005, 29:425-429.
14. Lauenstein T.C., Salman K., Morreira R., Heffron T., Spivey J.R., Martinez E., et al. Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience. AJR Am J Roentgenol 2007, 189:663-670.
15. Lutz A.M., Willmann J.K., Goepfert K., Marincek B., Weishaupt D. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology 2005, 237:520-528.
16. Karadeniz-Bilgili M., Braga L., Birchard K., Gerber D., Firat Z., Woosley J.T., et al. Hepatocellular carcinoma missed on gadolinium enhanced MR imaging, discovered in liver explants: retrospective evaluation. J Magn Reson Imaging 2006, 23:210-215.
17. Mitchell D.G., Saini S., Weinreb J., et al. Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteriol-enhanced MR imaging. Radiology 1994, 193:49-57.
18. Danet I., Semelka R.C., Leonardou P., Braga L., Vaidean G., Woosley J.T., et al. Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 2003, 181:809-817.
19. Yamaguchi R., Yano H., Nakashima O., Akiba J., Nishida N., Kurogi M., et al. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma. J Gastroenterol Hepatol 2006, 21:152-160.
20. Kanematsu M., Semelka R.C., Osada S., Amaoka N. Magnetic resonance imaging and expression of vascular endothelial growth factor in hepatocellular nodules in cirrhosis and hepatocellular carcinomas. Top Magn Reson Imaging 2005, 16:67-75.
21. Kanematsu M., Semeka R.C., Leonardou P., Mastropasqua M., Armao D., Vaidean G., et al. Angiogenesis in hepatocellular nodules: correlation of MR imaging and vascular endothelial growth factor. J Magn Reson Imaging 2004, 20:426-434.
22. Kelekis N.L., Semelka R.C., Worawattanakul S., et al. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. AJR Am J Roentgenol 1998, 170:1005-1013.
23. Van den Bos I.C., Hussain S.M., Dwarkasing R.S., Hop W.C., Zondervan P.E., de Man R.D., et al. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns. J Magn Reson Imaging 2007, 26:1548-1555.
24. Shah T.U., Semalka R.C., Pamuklar E., Firat Z., Gerber R.D., Shrestha R., et al. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI. Am J Gastroenterol 2006, 101:533-540.
25. Lazarevich N.L., Cheremnova O.A., Varga E.V., Ovchinnikov D.A., Kudrjavtseva E.I., Morozova O.V., et al. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology 2004, 39:1038-1047.
26. Liang R., Lau G.K., Kwong Y.L. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. J Clin Oncol 1999, 17:394-398.
27. Tamura Y., Yamagiwa S., Aoki Y., Kurita S., Suda T., Ohkoshi S., et al. Serum alpha-fetoprotein levels during and after interferon therapy and the development of hepatocellular carcinoma in patients with chronic hepatitis C. Dig Dis Sci 2009 Nov, 54(11):2530-2537. The Niigata Liver Disease Study Group, Epub 2008 Dec 18.